Entrada Therapeutics to Present at Upcoming Investor Conferences

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics

Related Keywords

Boston ,Massachusetts ,United States ,Dipal Doshi ,Karla Macdonald ,Nathan Dowden ,Linkedin ,Nasdaq ,Corporate Affairs Officer ,Healthcare Life Sciences Conference ,Health Care Conference ,Entrada Therapeutics Inc ,Endosomal Escape Vehicle ,Annual Healthcare Life Sciences ,Chief Executive Officer ,Annual Health Care ,Chief Operating Officer ,Orphan Bone ,Neuromuscular Diseases ,Investor Relations ,Corporate Affairs ,Region ,